Skip to main content

Table 2 Suspected cases of epilepsy (and prevalence of epilepsy) recorded by the CDDs (CDD+) and by the research team (Team+) in the villages where the verification was conducted, resulting prevalences, and ratio between the prevalences

From: Community-based door to door census of suspected people living with epilepsy: empowering community drug distributors to improve the provision of care to rural communities in Cameroon

District

Health area

Village

Pop*

No. SCEs

Prevalence

Ratio

CDD+ § Team+

CDD + μ Team-

CDD-β Team+

CDD+

Team+

CDD

Team

Monatélé

Eyen-Meyong

Nkol-Feb**

292

3

4

1.03

1.37

1.3

2

1

2

 

Mvomekak

Ebolmongo II

626

11

10

1.76

1.60

0.9

8

3

2

 

Ngomo

Ebanga

513

3

5

0.58

0.97

1.7

3

0

2

 

Nkog-Bong

Nkog-Bong

896

3

5

0.33

0.56

1.7

3

0

2

 

Nkolkosse

Nkolkosse

512

5

10

0.98

1.95

2.0

1

4

9

 

All

 

2839

25

34

0.88

1.20

1.4

17

8

17

Ndikiniméki

Boutourou

Boneck I

449

10

12

2.23

2.67

1.2

3

7

9

 

Boutourou

Kiboum I**

342

15

17

4.39

4.97

1.1

9

6

8

 

Makenéné

Mock Sud

459

6

7

1.31

1.53

1.2

3

3

4

 

Ndikiniméki

Ndikitole

363

4

2

1.10

0.55

0.5

2

2

0

 

Nyokon

Kinding Ndjabi

339

0

2

0

0.59

NA

0

0

2

 

All

 

1952

35

40

1.79

2.05

1.1

17

18

23

Pouma

Makob Lob Bako

Ngompem-Nkanla

114

7

6

6.14

5.26

0.9

4

3

2

 

Nkonga

Nkonga A

152

1

0

0.66

0

0

0

1

0

 

Pouma Centre

Song Woga

325

2

2

0.62

0.62

1.0

2

0

0

 

Saint André

Nkondjock II**

230

3

3

1.30

1.30

1.0

3

0

0

 

Song Simouth

Sakbayeme II

283

5

4

1.77

1.41

0.8

0

5

4

 

All

 

1104

18

15

1.63

1.36

0.8

9

9

6

ALL

  

5895

78

89

1.32

1.51

1.1

43

35

46

  1. * Population recorded by the CDDs
  2. ** Villages where both the population census and the census of SCE were verified by the project team
  3. § SCE recorded by both the CDDs and the research team (CDD+ Team+)
  4. μ SCE recorded by the CDDs only (CDD+ Team-)
  5. β SCE recorded by the research team only (CDD- Team+)